From: An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells
Formulation
aEE of % DOX:CUR
bLC% DOX:CUR
DOX-HGs
95
9.5
CUR-HGs
98
9.8
DOX/CUR-HGs
96: 98
4.8: 4.9
DOX/CUR-NGs
60: 93
3: 4.6